Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis.

Rosenberger CM, Podyminogin RL, Diercks AH, Treuting PM, Peschon JJ, Rodriguez D, Gundapuneni M, Weiss MJ, Aderem A.

PLoS Pathog. 2017 Apr 5;13(4):e1006305. doi: 10.1371/journal.ppat.1006305. eCollection 2017 Apr.

2.

Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model.

Rosenberger CM, Podyminogin RL, Askovich PS, Navarro G, Kaiser SM, Sanders CJ, McClaren JL, Tam VC, Dash P, Noonan JG, Jones BG, Surman SL, Peschon JJ, Diercks AH, Hurwitz JL, Doherty PC, Thomas PG, Aderem A.

J Gen Virol. 2014 Feb;95(Pt 2):350-62. doi: 10.1099/vir.0.058438-0. Epub 2013 Nov 16.

3.

Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells.

Sissons JR, Peschon JJ, Schmitz F, Suen R, Gilchrist M, Aderem A.

J Immunol. 2012 Jul 1;189(1):23-7. doi: 10.4049/jimmunol.1102477. Epub 2012 Jun 1.

4.

Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses.

Zak DE, Schmitz F, Gold ES, Diercks AH, Peschon JJ, Valvo JS, Niemistö A, Podolsky I, Fallen SG, Suen R, Stolyar T, Johnson CD, Kennedy KA, Hamilton MK, Siggs OM, Beutler B, Aderem A.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11536-41. doi: 10.1073/pnas.1107577108. Epub 2011 Jun 27.

5.

RIP4 regulates epidermal differentiation and cutaneous inflammation.

Rountree RB, Willis CR, Dinh H, Blumberg H, Bailey K, Dean C Jr, Peschon JJ, Holland PM.

J Invest Dermatol. 2010 Jan;130(1):102-12. doi: 10.1038/jid.2009.223.

6.

Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells.

Nagata T, McKinley L, Peschon JJ, Alcorn JF, Aujla SJ, Kolls JK.

J Immunol. 2008 Dec 1;181(11):7473-9.

7.

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, Peschon JJ.

J Exp Med. 2007 Oct 29;204(11):2603-14. Epub 2007 Oct 1.

8.

Protein kinase C-associated kinase is not required for the development of peripheral B lymphocyte populations.

Moran ST, Cariappa A, Liu H, Boboila C, Shi HN, Holland PM, Peschon JJ, Pillai S.

Mol Immunol. 2006 Apr;43(10):1694-9. Epub 2005 Oct 26.

PMID:
16256200
9.

Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis.

Lubberts E, Schwarzenberger P, Huang W, Schurr JR, Peschon JJ, van den Berg WB, Kolls JK.

J Immunol. 2005 Sep 1;175(5):3360-8.

10.

Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.

Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC.

J Biol Chem. 2004 Feb 13;279(7):5612-20. Epub 2003 Nov 18.

11.

Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis.

Sitnicka E, Brakebusch C, Martensson IL, Svensson M, Agace WW, Sigvardsson M, Buza-Vidas N, Bryder D, Cilio CM, Ahlenius H, Maraskovsky E, Peschon JJ, Jacobsen SE.

J Exp Med. 2003 Nov 17;198(10):1495-506. Epub 2003 Nov 10.

12.

Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity.

Black RA, Doedens JR, Mahimkar R, Johnson R, Guo L, Wallace A, Virca D, Eisenman J, Slack J, Castner B, Sunnarborg SW, Lee DC, Cowling R, Jin G, Charrier K, Peschon JJ, Paxton R.

Biochem Soc Symp. 2003;(70):39-52. Review.

PMID:
14587281
13.

An assessment of ADAMs in bone cells: absence of TACE activity prevents osteoclast recruitment and the formation of the marrow cavity in developing long bones.

Boissy P, Lenhard TR, Kirkegaard T, Peschon JJ, Black RA, Delaissé JM, del Carmen Ovejero M.

FEBS Lett. 2003 Oct 23;553(3):257-61.

14.

Semaphorin 7A promotes axon outgrowth through integrins and MAPKs.

Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL.

Nature. 2003 Jul 24;424(6947):398-405.

PMID:
12879062
15.

Nature's TRAIL--on a path to cancer immunotherapy.

Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.

Immunity. 2003 Jan;18(1):1-6. Review.

16.

Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha.

Sedger LM, Hou S, Osvath SR, Glaccum MB, Peschon JJ, van Rooijen N, Hyland L.

J Immunol. 2002 Dec 1;169(11):6193-201.

17.

T cells require TRAIL for optimal graft-versus-tumor activity.

Schmaltz C, Alpdogan O, Kappel BJ, Muriglan SJ, Rotolo JA, Ongchin J, Willis LM, Greenberg AS, Eng JM, Crawford JM, Murphy GF, Yagita H, Walczak H, Peschon JJ, van den Brink MR.

Nat Med. 2002 Dec;8(12):1433-7. Epub 2002 Nov 11.

PMID:
12426560
18.

A proteomic approach for the identification of cell-surface proteins shed by metalloproteases.

Guo L, Eisenman JR, Mahimkar RM, Peschon JJ, Paxton RJ, Black RA, Johnson RS.

Mol Cell Proteomics. 2002 Jan;1(1):30-6.

19.

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.

Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JH, Price VL, Marcus AJ, Maliszewski CR.

J Clin Invest. 2002 Apr;109(8):1031-40.

20.

Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC.

J Biol Chem. 2002 Apr 12;277(15):12838-45. Epub 2002 Jan 31.

21.

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.

Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ.

J Immunol. 2002 Feb 1;168(3):1356-61.

22.

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK.

J Exp Med. 2001 Aug 20;194(4):519-27.

23.

Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton.

Shi M, Dennis K, Peschon JJ, Chandrasekaran R, Mikecz K.

J Immunol. 2001 Jul 1;167(1):123-31.

25.

Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Kwon BS, Panoskaltsis-Mortari A, Kwak KB, Peschon JJ, Taylor PA.

J Immunol. 2001 Mar 1;166(5):3174-83.

26.

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER, Teepe M, Lyman SD, Peschon JJ.

Blood. 2000 Jun 1;95(11):3489-97.

27.

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.

Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA.

J Biol Chem. 2000 May 12;275(19):14608-14.

28.

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction.

Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL.

Proc Natl Acad Sci U S A. 2000 May 9;97(10):5456-61.

29.

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4.

Rio C, Buxbaum JD, Peschon JJ, Corfas G.

J Biol Chem. 2000 Apr 7;275(14):10379-87.

30.

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ.

J Exp Med. 2000 Mar 6;191(5):771-80.

31.

Roles of tumor necrosis factor receptor signaling during murine Escherichia coli pneumonia.

Mizgerd JP, Peschon JJ, Doerschuk CM.

Am J Respir Cell Mol Biol. 2000 Jan;22(1):85-91.

PMID:
10615069
32.
33.

RANK is essential for osteoclast and lymph node development.

Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J.

Genes Dev. 1999 Sep 15;13(18):2412-24.

34.

IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.

Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR.

J Immunol. 1999 Jul 15;163(2):920-6.

35.

Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa.

Skerrett SJ, Martin TR, Chi EY, Peschon JJ, Mohler KM, Wilson CB.

Am J Physiol. 1999 May;276(5):L715-27. doi: 10.1152/ajplung.1999.276.5.L715.

PMID:
10330027
36.

Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice.

Sadhukhan R, Santhamma KR, Reddy P, Peschon JJ, Black RA, Sen I.

J Biol Chem. 1999 Apr 9;274(15):10511-6.

37.

Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice.

Ortiz LA, Lasky J, Lungarella G, Cavarra E, Martorana P, Banks WA, Peschon JJ, Schmidts HL, Brody AR, Friedman M.

Am J Respir Cell Mol Biol. 1999 Apr;20(4):825-33.

PMID:
10101016
38.

Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

Ortiz LA, Lasky J, Hamilton RF Jr, Holian A, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, Friedman M.

Exp Lung Res. 1998 Nov-Dec;24(6):721-43.

PMID:
9839161
39.

An essential role for ectodomain shedding in mammalian development.

Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA.

Science. 1998 Nov 13;282(5392):1281-4.

40.

Overexpression of Bcl-2 does not rescue impaired B lymphopoiesis in IL-7 receptor-deficient mice but can enhance survival of mature B cells.

Maraskovsky E, Peschon JJ, McKenna H, Teepe M, Strasser A.

Int Immunol. 1998 Sep;10(9):1367-75.

PMID:
9786436
41.

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA.

J Biol Chem. 1998 Oct 23;273(43):27765-7.

42.
43.

TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection.

Page DM, Roberts EM, Peschon JJ, Hedrick SM.

J Immunol. 1998 Jan 1;160(1):120-33.

44.

TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.

Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM.

J Immunol. 1998 Jan 15;160(2):943-52.

45.

Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors.

Ruby J, Bluethmann H, Peschon JJ.

J Exp Med. 1997 Nov 3;186(9):1591-6.

46.
47.

Phenotypic and functional characterization of mice that lack the type I receptor for IL-1.

Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ.

J Immunol. 1997 Oct 1;159(7):3364-71.

PMID:
9317135
48.
49.

Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice.

Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A.

Cell. 1997 Jun 27;89(7):1011-9.

50.

Defective T-cell receptor gamma gene rearrangement in interleukin-7 receptor knockout mice.

Candéias S, Peschon JJ, Muegge K, Durum SK.

Immunol Lett. 1997 Jun 1;57(1-3):9-14.

PMID:
9232418

Supplemental Content

Loading ...
Support Center